Armata Pharmaceuticals (ARMP) Accumulated Depreciation & Amortization (2016 - 2017)
Historic Accumulated Depreciation & Amortization for Armata Pharmaceuticals (ARMP) over the last 5 years, with Q4 2017 value amounting to $1.2 million.
- Armata Pharmaceuticals' Accumulated Depreciation & Amortization rose 2553.65% to $1.2 million in Q4 2017 from the same period last year, while for Dec 2017 it was $1.2 million, marking a year-over-year increase of 2553.65%. This contributed to the annual value of $1.2 million for FY2017, which is 2553.65% up from last year.
- Armata Pharmaceuticals' Accumulated Depreciation & Amortization amounted to $1.2 million in Q4 2017, which was up 2553.65% from $932000.0 recorded in Q4 2016.
- Armata Pharmaceuticals' Accumulated Depreciation & Amortization's 5-year high stood at $1.2 million during Q4 2017, with a 5-year trough of -$127000.0 in Q4 2014.
- In the last 5 years, Armata Pharmaceuticals' Accumulated Depreciation & Amortization had a median value of $604000.0 in 2015 and averaged $586000.0.
- Its Accumulated Depreciation & Amortization has fluctuated over the past 5 years, first tumbled by 13618.23% in 2014, then skyrocketed by 57559.06% in 2015.
- Armata Pharmaceuticals' Accumulated Depreciation & Amortization (Quarter) stood at $351000.0 in 2013, then tumbled by 136.18% to -$127000.0 in 2014, then surged by 575.59% to $604000.0 in 2015, then soared by 54.3% to $932000.0 in 2016, then rose by 25.54% to $1.2 million in 2017.
- Its Accumulated Depreciation & Amortization stands at $1.2 million for Q4 2017, versus $932000.0 for Q4 2016 and $604000.0 for Q4 2015.